113 related articles for article (PubMed ID: 37997798)
1. Comparative Analysis of miRNA and EMT Markers in Metastatic Colorectal Cancer.
Hanusova V; Matouskova P; Manethova M; Soukup J; John S; Zofka M; Vošmikova H; Krbal L; Rudolf E
Cancer Invest; 2023 Dec; 41(10):837-847. PubMed ID: 37997798
[TBL] [Abstract][Full Text] [Related]
2. Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer.
Huang L; Wang X; Wen C; Yang X; Song M; Chen J; Wang C; Zhang B; Wang L; Iwamoto A; Wang J; Liu H
Sci Rep; 2015 Aug; 5():13350. PubMed ID: 26302825
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
Zhang X; Bai J; Yin H; Long L; Zheng Z; Wang Q; Chen F; Yu X; Zhou Y
Mol Oncol; 2020 Oct; 14(10):2589-2608. PubMed ID: 32679610
[TBL] [Abstract][Full Text] [Related]
6. Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front.
Jepsen RK; Novotny GW; Klarskov LL; Bang-Berthelsen CH; Haakansson IT; Hansen A; Christensen IJ; Riis LB; Høgdall E
Hum Pathol; 2018 Oct; 80():231-238. PubMed ID: 29902577
[TBL] [Abstract][Full Text] [Related]
7. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.
Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D
Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
10. mir-145-5p is a suppressor of colorectal cancer at early stage, while promotes colorectal cancer metastasis at late stage through regulating AKT signaling evoked EMT-mediated anoikis.
Cheng X; Shen T; Liu P; Fang S; Yang Z; Li Y; Dong J
BMC Cancer; 2022 Nov; 22(1):1151. PubMed ID: 36348305
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B
Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214
[TBL] [Abstract][Full Text] [Related]
13. Role of Mir-452-5p Overexpression in Epithelial-Mesenchymal Transition (EMT) in Early-stage Colorectal Cancer.
Koyama Y; Fujihara S; Chiyo T; Matsui T; Hamaya S; Fujita K; Tani J; Morishita A; Kobara H; Ono M; Iwama H; Masaki T
In Vivo; 2023; 37(5):1980-1990. PubMed ID: 37652512
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
15. Investigating intra-tumor heterogeneity and expression gradients of miR-21, miR-92a and miR-200c and their potential of predicting lymph node metastases in early colorectal cancer.
Jepsen RK; Novotny GW; Klarskov LL; Christensen IJ; Høgdall E; Riis LB
Exp Mol Pathol; 2016 Oct; 101(2):187-196. PubMed ID: 27565378
[TBL] [Abstract][Full Text] [Related]
16. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
[TBL] [Abstract][Full Text] [Related]
17. microRNA-182 targets special AT-rich sequence-binding protein 2 to promote colorectal cancer proliferation and metastasis.
Yang MH; Yu J; Jiang DM; Li WL; Wang S; Ding YQ
J Transl Med; 2014 May; 12():109. PubMed ID: 24884732
[TBL] [Abstract][Full Text] [Related]
18. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
19. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
20. MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients.
Pichler M; Ress AL; Winter E; Stiegelbauer V; Karbiener M; Schwarzenbacher D; Scheideler M; Ivan C; Jahn SW; Kiesslich T; Gerger A; Bauernhofer T; Calin GA; Hoefler G
Br J Cancer; 2014 Mar; 110(6):1614-21. PubMed ID: 24504363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
